![Evert Schimmelpennink](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Evert Schimmelpennink
Président chez
CONTINEUM THERAPEUTICS, INC.
Fortune : 403 999 $ au 31/08/2026
Profil
Evert B. Schimmelpennink is President, CEO, Secretary & Director at LENZ Therapeutics, Inc. since 2021.
Mr. Schimmelpennink is Chairman at Contineum Therapeutics, Inc. since 2022.
Former roles include President, CEO, CFO, Secretary & Director at The Pelican, Inc. from 2019 to 2020; Chief Executive Officer at Alvotech hf from 2015 to 2017; Independent Director at iBio, Inc. from 2021 to 2026; Vice President-Global Sterile Injectables at Pfizer Inc. in 2015; Vice President-Global Generics at Hospira, Inc. from 2012 to 2015; and Vice President-Sales & Marketing at Synthon BV from 2008 to 2011.
Education includes graduate studies at Wageningen University and undergraduate studies at Arnhem Business School Bachelor.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,25% | 14/04/2026 | 77 543 ( 0,25% ) | 403 999 $ | 31/08/2026 |
IBIO, INC. -.--% | 20/11/2025 | 0 ( -.--% ) | - $ | 31/08/2026 |
| 26/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Evert Schimmelpennink
| Sociétés | Poste | Début |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Président | - |
Anciens postes connus de Evert Schimmelpennink
| Sociétés | Poste | Fin |
|---|---|---|
| IBIO, INC. | Directeur/Membre du Conseil | 07/05/2026 |
| PFENEX INC. | Directeur Général | 01/10/2020 |
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur Général | 01/07/2017 |
| PFIZER INC. | Corporate Officer/Principal | 01/11/2015 |
| HOSPIRA, INC. | Corporate Officer/Principal | 01/01/2015 |
Formation de Evert Schimmelpennink
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
Synthon BV
 Synthon BV Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and manufactures generics | Health Technology |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Wageningen University
 Wageningen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
